Treatment of Advanced Metastatic Melanoma

The introduction in clinical practice of new drug compounds both targeted therapies anti-BRAF and checkpoint inhibitors have largely improved our potential to manage advanced metastatic melanoma patients. This has led to a significant improvement in terms of response rates and particularly in the o...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pietro Quaglino, Paolo Fava, Luca Tonella, Marco Rubatto, Simone Ribero, Maria Teresa Ferro
Format: article
Langue:EN
Publié: Mattioli1885 2021
Sujets:
Accès en ligne:https://doaj.org/article/fc9ee1c4f4f647f099d8873a21b3f64b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!